Business Description
Amphastar Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US03209R1032
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.35 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.87 | |||||
Debt-to-EBITDA | 2.08 | |||||
Interest Coverage | 5.69 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.64 | |||||
Beneish M-Score | -2.48 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.5 | |||||
3-Year EBITDA Growth Rate | 94.6 | |||||
3-Year EPS without NRI Growth Rate | 342.5 | |||||
3-Year FCF Growth Rate | 79.1 | |||||
3-Year Book Growth Rate | 16.2 | |||||
Future 3-5Y EPS without NRI Growth Rate | 24.08 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.04 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58 | |||||
9-Day RSI | 62.44 | |||||
14-Day RSI | 61.87 | |||||
6-1 Month Momentum % | 14.31 | |||||
12-1 Month Momentum % | 1.93 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.52 | |||||
Quick Ratio | 2.63 | |||||
Cash Ratio | 1.59 | |||||
Days Inventory | 126.15 | |||||
Days Sales Outstanding | 62.28 | |||||
Days Payable | 32.66 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | -15.09 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 54.68 | |||||
Operating Margin % | 32.25 | |||||
Net Margin % | 23.36 | |||||
FCF Margin % | 25.05 | |||||
ROE % | 25.94 | |||||
ROA % | 11.1 | |||||
ROIC % | 18.19 | |||||
ROC (Joel Greenblatt) % | 70.25 | |||||
ROCE % | 19.1 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 15.92 | |||||
Forward PE Ratio | 11.2 | |||||
PE Ratio without NRI | 12.43 | |||||
Shiller PE Ratio | 57.42 | |||||
Price-to-Owner-Earnings | 15.55 | |||||
PEG Ratio | 0.16 | |||||
PS Ratio | 3.7 | |||||
PB Ratio | 3.42 | |||||
Price-to-Tangible-Book | 21.42 | |||||
Price-to-Free-Cash-Flow | 14.81 | |||||
Price-to-Operating-Cash-Flow | 12.41 | |||||
EV-to-EBIT | 11.65 | |||||
EV-to-EBITDA | 9.49 | |||||
EV-to-Revenue | 3.98 | |||||
EV-to-FCF | 15.96 | |||||
Price-to-Projected-FCF | 1.66 | |||||
Price-to-Median-PS-Value | 1.18 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.49 | |||||
Price-to-Graham-Number | 3.42 | |||||
Earnings Yield (Greenblatt) % | 8.59 | |||||
FCF Yield % | 7.32 | |||||
Forward Rate of Return (Yacktman) % | 23.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Amphastar Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 660.036 | ||
EPS (TTM) (€) | 2.9 | ||
Beta | 0.6 | ||
Volatility % | 33.74 | ||
14-Day RSI | 61.87 | ||
14-Day ATR (€) | 0.620022 | ||
20-Day SMA (€) | 43.621 | ||
12-1 Month Momentum % | 1.93 | ||
52-Week Range (€) | 34.1 - 58.5 | ||
Shares Outstanding (Mil) | 48.96 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Amphastar Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Amphastar Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Amphastar Pharmaceuticals Inc Frequently Asked Questions
What is Amphastar Pharmaceuticals Inc(FRA:29A)'s stock price today?
When is next earnings date of Amphastar Pharmaceuticals Inc(FRA:29A)?
Does Amphastar Pharmaceuticals Inc(FRA:29A) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |